OrthoPediatrics (KIDS) Stock Forecast, Price Target & Predictions
KIDS Stock Forecast
OrthoPediatrics stock forecast is as follows: an average price target of $40.80 (represents a 26.39% upside from KIDS’s last price of $32.28) and a rating consensus of 'Buy', based on 7 wall street analysts offering a 1-year stock forecast.
KIDS Price Target
The average price target for OrthoPediatrics (KIDS) is $40.80 based on 1-year price targets from 7 Wall Street analysts in the past 3 months, with a price target range of $44.00 to $34.00. This represents a potential 26.39% upside from KIDS's last price of $32.28.
KIDS Analyst Ratings
According to 7 Wall Street analysts, OrthoPediatrics's rating consensus is 'Buy'. The analyst rating breakdown for KIDS stock is 0 'Strong Buy' (0.00%), 7 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
OrthoPediatrics Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 13, 2024 | Mike Matson | Needham | $42.00 | $31.60 | 32.91% | 30.11% |
| Sep 13, 2024 | Kaila Krum | Truist Financial | $34.00 | $31.60 | 7.59% | 5.33% |
| Sep 06, 2024 | Matt O'Brien | Piper Sandler | $44.00 | $29.88 | 47.26% | 36.31% |
| Sep 06, 2024 | Ryan Zimmerman | BTIG | $44.00 | $29.88 | 47.26% | 36.31% |
| Jul 16, 2024 | Richard Newitter | Truist Financial | $35.00 | $34.44 | 1.63% | 8.43% |
| May 07, 2024 | Rick Wise | Stifel Nicolaus | $40.00 | $34.70 | 15.27% | 23.92% |
| Aug 05, 2022 | - | Truist Financial | $66.00 | $55.06 | 19.87% | 104.46% |
| Jul 18, 2022 | - | BTIG | $61.00 | $42.99 | 41.89% | 88.97% |
| Jul 18, 2022 | - | Stifel Nicolaus | $50.00 | $42.99 | 16.31% | 54.89% |
| May 05, 2022 | - | Needham | $59.00 | $44.13 | 33.70% | 82.78% |
The latest OrthoPediatrics stock forecast, released on Sep 13, 2024 by Mike Matson from Needham, set a price target of $42.00, which represents a 32.91% increase from the stock price at the time of the forecast ($31.60), and a 30.11% increase from KIDS last price ($32.28).
OrthoPediatrics Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 4 | 5 | 6 |
| Avg Price Target | $41.00 | $39.80 | $39.83 |
| Last Closing Price | $32.28 | $32.28 | $32.28 |
| Upside/Downside | 27.01% | 23.30% | 23.39% |
In the current month, the average price target of OrthoPediatrics stock is $41.00, according to 4 Wall Street analysts offering twelve months forecast. The average price target represents a 27.01% increase as opposed to OrthoPediatrics's last price of $32.28. This month's average price target is up 3.02% compared to last quarter, and up 2.94% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 13, 2024 | Truist Financial | Buy | Buy | Hold |
| Sep 13, 2024 | Needham | Buy | Buy | Hold |
| Sep 06, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Sep 06, 2024 | BTIG | Buy | Buy | Hold |
| May 07, 2024 | Needham | Market Outperform | Market Outperform | Hold |
| Mar 07, 2024 | Truist Financial | Market Outperform | Market Outperform | Hold |
| Oct 04, 2023 | Bernstein | Outperform | Outperform | Hold |
| Oct 04, 2023 | BTIG | Buy | Buy | Hold |
| Oct 04, 2023 | Barclays | Buy | Buy | Hold |
| Jan 10, 2023 | Needham | Buy | Buy | Hold |
OrthoPediatrics's last stock rating was published by Truist Financial on Sep 13, 2024. The company gave KIDS a "Buy" rating, the same as its previous rate.
OrthoPediatrics Financial Forecast
OrthoPediatrics Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $37.61M | $39.97M | $39.56M | $31.59M | $30.99M | $34.95M | - | $23.42M | $24.81M | $25.08M | $26.70M | $21.46M | $18.92M | $22.20M | $13.59M | $16.36M | $18.95M | $20.74M |
| Avg Forecast | $67.24M | $71.78M | $70.38M | $59.43M | $60.44M | $64.27M | $62.58M | $52.79M | $50.43M | $53.73M | $52.52M | $41.78M | $37.73M | $40.37M | $39.13M | $29.31M | $31.00M | $36.15M | $32.40M | $22.76M | $24.71M | $26.28M | $24.25M | $19.90M | $20.32M | $19.97M | $11.43M | $17.04M | $18.34M | $19.87M |
| High Forecast | $67.69M | $72.26M | $70.85M | $59.82M | $60.84M | $64.70M | $63.00M | $53.15M | $50.76M | $53.90M | $52.88M | $42.06M | $37.74M | $40.64M | $39.40M | $29.51M | $31.21M | $36.40M | $32.40M | $23.23M | $25.22M | $26.82M | $24.75M | $20.31M | $20.73M | $20.38M | $11.66M | $17.39M | $18.72M | $20.28M |
| Low Forecast | $66.33M | $70.80M | $69.42M | $58.62M | $59.61M | $63.40M | $61.73M | $52.08M | $49.74M | $53.41M | $51.81M | $41.21M | $37.72M | $39.82M | $38.60M | $28.91M | $30.58M | $35.66M | $32.40M | $21.49M | $23.33M | $24.82M | $22.90M | $18.79M | $19.18M | $18.86M | $10.79M | $16.09M | $17.32M | $18.77M |
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 0.99% | 1.01% | 1.08% | 1.00% | 0.97% | - | 1.03% | 1.00% | 0.95% | 1.10% | 1.08% | 0.93% | 1.11% | 1.19% | 0.96% | 1.03% | 1.04% |
OrthoPediatrics's average Quarter revenue forecast for Mar 24 based on 2 analysts is $41.78M, with a low forecast of $41.21M, and a high forecast of $42.06M. KIDS's average Quarter revenue forecast represents a 11.08% increase compared to the company's last Quarter revenue of $37.61M (Dec 23).
OrthoPediatrics EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-8.07M | $-3.52M | $-1.22M | $-5.41M | $-4.92M | $-1.01M | - | $-3.32M | $3.04M | $776.00K | $-853.00K | $-7.42M | $-11.80M | $-1.12M | $-6.14M | $-3.19M | $-2.71M | $-21.00K |
| Avg Forecast | $-5.92M | $-6.32M | $-6.20M | $-5.23M | $-5.32M | $-5.66M | $-5.51M | $-4.65M | $-4.44M | $-4.73M | $-4.63M | $-3.68M | $-3.32M | $-3.56M | $-3.45M | $-2.58M | $-2.73M | $1.09M | $-2.85M | $-6.46M | $-2.18M | $993.88K | $-1.13M | $-8.17M | $-1.79M | $-1.37M | $-3.91M | $-2.55M | $-1.62M | $-19.76K |
| High Forecast | $-5.84M | $-6.24M | $-6.11M | $-5.16M | $-5.25M | $-5.58M | $-5.44M | $-4.59M | $-4.38M | $-4.70M | $-4.56M | $-3.63M | $-3.32M | $-3.51M | $-3.40M | $-2.55M | $-2.69M | $1.31M | $-2.85M | $-5.17M | $-2.05M | $1.19M | $-906.62K | $-6.53M | $-1.69M | $-1.10M | $-3.13M | $-2.04M | $-1.53M | $-15.81K |
| Low Forecast | $-5.96M | $-6.36M | $-6.24M | $-5.27M | $-5.36M | $-5.70M | $-5.55M | $-4.68M | $-4.47M | $-4.75M | $-4.66M | $-3.70M | $-3.32M | $-3.58M | $-3.47M | $-2.60M | $-2.75M | $874.61K | $-2.85M | $-7.75M | $-2.22M | $795.10K | $-1.36M | $-9.80M | $-1.83M | $-1.64M | $-4.69M | $-3.06M | $-1.65M | $-23.72K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.43% | 0.99% | 0.35% | 2.10% | 1.80% | -0.92% | - | 0.51% | -1.40% | 0.78% | 0.75% | 0.91% | 6.59% | 0.82% | 1.57% | 1.25% | 1.68% | 1.06% |
1 analysts predict KIDS's average Quarter EBITDA for Mar 22 to be $-6.46M, with a high of $-5.17M and a low of $-7.75M. This is -312.39% lower than OrthoPediatrics's previous annual EBITDA (Dec 21) of $3.04M.
OrthoPediatrics Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-6.69M | $-4.59M | $-2.89M | $-6.81M | $-7.85M | $18.54M | - | $-9.10M | $72.00K | $-2.20M | $-3.76M | $-10.38M | $-14.01M | $-4.54M | $-9.45M | $-4.95M | $-5.43M | $-2.66M |
| Avg Forecast | $-4.91M | $-1.87M | $-1.55M | $-11.59M | $-6.35M | $-4.82M | $-4.29M | $-8.28M | $-7.34M | $-5.25M | $-6.08M | $-9.37M | $-6.22M | $-4.94M | $-4.74M | $-8.15M | $-5.30M | $-3.10M | $-4.30M | $-6.64M | $-7.00M | $-2.81M | $-4.99M | $-11.42M | $-6.22M | $-5.56M | $-6.02M | $-3.96M | $-5.70M | $-2.51M |
| High Forecast | $-4.82M | $-1.84M | $-1.52M | $-11.39M | $-6.24M | $-4.74M | $-4.21M | $-8.14M | $-7.21M | $-3.04M | $-5.98M | $-9.20M | $-5.77M | $-4.85M | $-4.66M | $-8.00M | $-5.21M | $-2.48M | $-4.30M | $-5.31M | $-6.49M | $-2.25M | $-3.99M | $-9.13M | $-5.77M | $-4.45M | $-4.81M | $-3.16M | $-5.28M | $-2.01M |
| Low Forecast | $-4.95M | $-1.89M | $-1.56M | $-11.69M | $-6.40M | $-4.86M | $-4.32M | $-8.35M | $-7.40M | $-8.29M | $-6.14M | $-9.45M | $-6.44M | $-4.98M | $-4.78M | $-8.22M | $-5.35M | $-3.71M | $-4.30M | $-7.97M | $-7.19M | $-3.38M | $-5.99M | $-13.70M | $-6.39M | $-6.68M | $-7.22M | $-4.75M | $-5.85M | $-3.01M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.08% | 0.93% | 0.61% | 0.84% | 1.48% | -5.99% | - | 1.37% | -0.01% | 0.78% | 0.75% | 0.91% | 2.25% | 0.82% | 1.57% | 1.25% | 0.95% | 1.06% |
OrthoPediatrics's average Quarter net income forecast for Dec 22 is $-5.30M, with a range of $-5.35M to $-5.21M. KIDS's average Quarter net income forecast represents a -128.59% decrease compared to the company's last Quarter net income of $18.54M (Sep 22).
OrthoPediatrics SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $32.03M | $32.09M | $32.82M | $29.88M | $27.50M | $27.04M | - | $22.93M | $22.03M | $20.90M | $21.96M | $20.99M | $19.47M | $19.06M | $16.20M | $15.45M | $15.58M | $16.04M |
| Avg Forecast | $57.16M | $61.01M | $59.82M | $50.51M | $51.37M | $54.63M | $53.20M | $44.88M | $42.86M | $45.67M | $44.65M | $35.52M | $32.07M | $34.32M | $33.26M | $24.91M | $26.35M | $29.44M | $27.54M | $16.73M | $21.00M | $22.34M | $20.62M | $16.91M | $17.27M | $16.97M | $10.31M | $12.36M | $15.59M | $15.09M |
| High Forecast | $57.54M | $61.42M | $60.22M | $50.85M | $51.72M | $55.00M | $53.55M | $45.18M | $43.15M | $45.82M | $44.95M | $35.75M | $32.08M | $34.55M | $33.49M | $25.08M | $26.53M | $35.33M | $27.54M | $20.07M | $21.43M | $22.80M | $21.04M | $17.26M | $17.62M | $17.32M | $12.38M | $14.83M | $15.91M | $18.11M |
| Low Forecast | $56.38M | $60.18M | $59.01M | $49.83M | $50.67M | $53.89M | $52.47M | $44.27M | $42.28M | $45.40M | $44.04M | $35.03M | $32.06M | $33.85M | $32.81M | $24.58M | $25.99M | $23.55M | $27.54M | $13.38M | $19.83M | $21.10M | $19.47M | $15.97M | $16.31M | $16.03M | $8.25M | $9.88M | $14.72M | $12.08M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 0.94% | 0.99% | 1.20% | 1.04% | 0.92% | - | 1.37% | 1.05% | 0.94% | 1.07% | 1.24% | 1.13% | 1.12% | 1.57% | 1.25% | 1.00% | 1.06% |
OrthoPediatrics's average Quarter SG&A projection for Mar 24 is $35.52M, based on 2 Wall Street analysts, with a range of $35.03M to $35.75M. The forecast indicates a 10.87% rise compared to KIDS last annual SG&A of $32.03M (Dec 23).
OrthoPediatrics EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.00 | $-0.20 | $-0.13 | $-0.30 | $-0.35 | $0.88 | - | $-0.47 | - | $-0.11 | $-0.19 | $-0.54 | $-0.73 | $-0.24 | $-0.54 | $-0.30 | $-0.36 | $-0.18 |
| Avg Forecast | $-0.21 | $-0.08 | $-0.07 | $-0.50 | $-0.27 | $-0.21 | $-0.19 | $-0.36 | $-0.32 | $-0.23 | $-0.26 | $-0.40 | $-0.27 | $-0.21 | $-0.20 | $-0.35 | $-0.23 | $-0.17 | $-0.19 | $-0.35 | $-0.31 | $-0.28 | $-0.32 | $-0.27 | $-0.27 | $-0.31 | $-0.38 | $-0.25 | $-0.25 | $-0.17 |
| High Forecast | $-0.21 | $-0.08 | $-0.07 | $-0.49 | $-0.27 | $-0.20 | $-0.18 | $-0.35 | $-0.31 | $-0.13 | $-0.26 | $-0.40 | $-0.25 | $-0.21 | $-0.20 | $-0.35 | $-0.22 | $-0.17 | $-0.19 | $-0.33 | $-0.29 | $-0.26 | $-0.30 | $-0.25 | $-0.25 | $-0.28 | $-0.35 | $-0.24 | $-0.23 | $-0.16 |
| Low Forecast | $-0.21 | $-0.08 | $-0.07 | $-0.51 | $-0.28 | $-0.21 | $-0.19 | $-0.36 | $-0.32 | $-0.36 | $-0.27 | $-0.41 | $-0.28 | $-0.22 | $-0.21 | $-0.36 | $-0.23 | $-0.18 | $-0.19 | $-0.36 | $-0.32 | $-0.29 | $-0.33 | $-0.27 | $-0.28 | $-0.31 | $-0.39 | $-0.26 | $-0.26 | $-0.18 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | 0.94% | 0.63% | 0.85% | 1.53% | -5.06% | - | 1.33% | -0.01% | 0.40% | 0.59% | 2.03% | 2.67% | 0.78% | 1.42% | 1.18% | 1.44% | 1.03% |
According to 1 Wall Street analysts, OrthoPediatrics's projected average Quarter EPS for Dec 22 is $-0.23, with a low estimate of $-0.23 and a high estimate of $-0.22. This represents a -126.02% decrease compared to KIDS previous annual EPS of $0.88 (Sep 22).
OrthoPediatrics Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| CVRX | CVRx | $7.85 | $15.83 | 101.66% | Buy |
| IRTC | iRhythm | $76.61 | $144.20 | 88.23% | Buy |
| OFIX | Orthofix Medical | $16.76 | $31.00 | 84.96% | - |
| NPCE | NeuroPace | $7.43 | $12.88 | 73.35% | Buy |
| FNA | Paragon 28 | $7.39 | $11.50 | 55.62% | Buy |
| SGHT | Sight Sciences | $6.95 | $10.33 | 48.63% | Hold |
| LUNG | Pulmonx | $8.31 | $12.25 | 47.41% | Buy |
| LIVN | LivaNova | $48.53 | $71.25 | 46.82% | Buy |
| CNMD | CONMED | $75.40 | $101.00 | 33.95% | Buy |
| SIBN | SI-BONE | $15.73 | $20.00 | 27.15% | Buy |
| KIDS | OrthoPediatrics | $32.28 | $40.80 | 26.39% | Buy |
| SRDX | Surmodics | $39.36 | $39.50 | 0.36% | Buy |
| GKOS | Glaukos | $126.28 | $101.56 | -19.58% | Buy |
KIDS Forecast FAQ
Is OrthoPediatrics a good buy?
Yes, according to 7 Wall Street analysts, OrthoPediatrics (KIDS) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 7 'Buy' recommendations, accounting for 100.00% of KIDS's total ratings.
What is KIDS's price target?
OrthoPediatrics (KIDS) average price target is $40.8 with a range of $34 to $44, implying a 26.39% from its last price of $32.28. The data is based on 7 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will OrthoPediatrics stock go up soon?
According to Wall Street analysts' prediction for KIDS stock, the company can go up by 26.39% (from the last price of $32.28 to the average price target of $40.8), up by 36.31% based on the highest stock price target, and up by 5.33% based on the lowest stock price target.
Can OrthoPediatrics stock reach $50?
KIDS's average twelve months analyst stock price target of $40.8 does not support the claim that OrthoPediatrics can reach $50 in the near future.
What is OrthoPediatrics's current price target trend?
4 Wall Street analysts forecast a $41 price target for OrthoPediatrics (KIDS) this month, up 27.01% from its last price of $32.28. Compared to the last 3 and 12 months, the average price target increased by 23.30% and increased by 23.39%, respectively.
What are OrthoPediatrics's analysts' financial forecasts?
OrthoPediatrics's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $240.08M (high $241.69M, low $236.82M), average EBITDA is $-21.144M (high $-20.856M, low $-21.285M), average net income is $-23.738M (high $-23.318M, low $-23.944M), average SG&A $204.08M (high $205.45M, low $201.31M), and average EPS is $-1.026 (high $-1.007, low $-1.035). KIDS's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $268.82M (high $270.62M, low $265.17M), average EBITDA is $-23.675M (high $-23.353M, low $-23.833M), average net income is $-19.921M (high $-19.569M, low $-20.094M), average SG&A $228.51M (high $230.04M, low $225.4M), and average EPS is $-0.861 (high $-0.845, low $-0.868).
Did the KIDS's actual financial results beat the analysts' financial forecasts?
Based on OrthoPediatrics's last annual report (Dec 2023), the company's revenue was $148.73M, beating the average analysts forecast of $146.54M by 1.49%. Apple's EBITDA was $-25.766M, beating the average prediction of $-12.906M by 99.64%. The company's net income was $-20.974M, missing the average estimation of $-24.044M by -12.77%. Apple's SG&A was $126.82M, beating the average forecast of $124.57M by 1.81%. Lastly, the company's EPS was $-0.0009, missing the average prediction of $-1.039 by -99.91%. In terms of the last quarterly report (Dec 2023), OrthoPediatrics's revenue was $37.61M, missing the average analysts' forecast of $37.73M by -0.31%. The company's EBITDA was $-8.066M, beating the average prediction of $-3.323M by 142.75%. OrthoPediatrics's net income was $-6.691M, beating the average estimation of $-6.215M by 7.65%. The company's SG&A was $32.03M, missing the average forecast of $32.07M by -0.12%. Lastly, the company's EPS was $-0.0003, missing the average prediction of $-0.269 by -99.89%